Sign In
Get Clay Free →

Suggestions

    Andrew Carr

    Clinical Scientist at Procter & Gamble

    Professional Background

    Andrew Carr is a distinguished Clinical Scientist with over 12 years of extensive experience in the pharmaceutical and healthcare sectors. Committed to enhancing the quality of baby care products, he currently serves as a Clinical Scientist in Global Baby Care at Procter & Gamble, a position he has held for the past three years. In this capacity, Andrew is responsible for the clinical strategies, design, and oversight of clinical programs for Pampers products across various global markets including the United States, Europe, Central and South America, and Asia. His role emphasizes the importance of ensuring that Pampers products meet stringent clinical safety and effectiveness standards, thereby contributing to customer satisfaction and product excellence.

    In his previous role as a Clinical Scientist within the Personal Healthcare Respiratory Area at Procter & Gamble, Andrew shaped the clinical strategies and designs for various products addressing cough, cold, allergy, and sleep-related issues. His expertise in this domain allowed him to develop robust clinical frameworks that facilitate product innovation and regulatory compliance. Furthermore, as a Regulatory Affairs Manager, Andrew showcased his capacity to lead regulatory strategies, ensuring seamless market entry for marketed and pre-NDA products, particularly in the IND stage. Throughout his career, Andrew has managed critical correspondence with government agencies, including the Food and Drug Administration (FDA) and the Drug Enforcement Agency (DEA), to navigate complex regulatory landscapes successfully.

    Andrew’s solid foundation in pharmaceutical project leadership spans over five years, where he has demonstrated leadership in projects addressing cardiovascular diseases, among other areas. His in-depth understanding of heart failure, mechanisms of muscle contraction, diuretics, vascular disorders, and peripheral vascular disease reflects his versatility and comprehensive knowledge of various therapeutic areas. Andrew possesses a wealth of experience in executing Thorough QT studies complying with S7B/E14 guidances, evaluating licensing and acquisition opportunities, and developing regulatory strategies to ensure the pharmaceutical products' successful trials and market presence.

    Education and Achievements

    Andrew graduated with a PhD in Molecular, Cellular, and Biochemical Pharmacology from the University of Cincinnati College of Medicine, an institution renowned for its focus on life sciences research and training. His educational journey laid the groundwork for his expertise in pharmacology, with a focus on both in vitro and in vivo models of disease. Prior to obtaining his PhD, Andrew earned a Bachelor of Science in Biological Chemistry from the College of Mount St. Joseph, where he honed his analytical skills and foundational knowledge necessary for his future endeavors in the pharmaceutical field.

    Notable academic achievements during his studies included hands-on research experience that not only sparked his interest in molecular pharmacology but also developed the critical thinking skills necessary for problem-solving in real-world clinical settings. This academic background, combined with his practical experience, has positioned Andrew as a thought leader in pharmacological advancements and clinical program oversight.

    Achievements

    Throughout his impressive career, Andrew Carr has made significant contributions to the fields of clinical research and pharmaceutical development. His adeptness at interfacing with regulatory agencies has facilitated many products' successful transitions from concept to market, ensuring the highest standards of safety and efficacy. His leadership in clinical strategy development has enabled the launch of cutting-edge healthcare products that directly improve patient outcomes.

    Andrew's extensive experience managing the global import and export of controlled substances as well as the execution of pivotal studies demonstrates his vital role in maintaining compliance and advancing clinical research protocols. His expertise in molecular, cellular, biochemical, and receptor pharmacology equips him with the unique ability to drive product innovation while adhering to regulatory standards. As he continues to lead clinical strategies for Pampers, Andrew remains at the forefront of developing products that prioritize infant safety and efficacy, thus enhancing the lives of parents and their children around the world.

    tags':['Clinical Scientist','Global Baby Care','Pharmaceutical Experience','Regulatory Affairs','Clinical Programs','Pharmacology','Product Development','Pampers','Clinical Strategy','Public Health','Respiratory Care','Cardiovascular Disease','FDA','Drug Regulations','Pharmaceutical Leadership'],

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ],

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    },

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    ,

    :

    },

    :

    ,

    :

    ,

    :

    ,

    :

    },

    :

    ,

    :

    },

    :

    },

    :

    }},{

    :

    }}]} .<|vq_10628|>--- In the fast-evolving healthcare environment, Andrew's combination of scientific acumen and strategic regulatory insight has made him a pivotal figure in developing innovative solutions for age-old challenges, showcasing a commitment to public health that continues to benefit communities worldwide. As he transitions into further roles within the healthcare sector, Andrew Carr remains a prominent leader, driving advances in clinical science for the betterment of patient care and product efficacy.

    tags

    questions

    A
    Add to my network

    Location

    Cincinnati, Ohio Area